Postmarketing Adverse Experience Reporting for Human Drug and Licensed Biological Products: Clarification of What to Report
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 27, 1997
April 27, 2020
89a5f407-ec41-4ec0-bf36-c5a19b96b776
Related Documents
Monoclonal Antibodies Used as Reagents in Drug Manufacturing
Guidance DocumentMarch 1, 2001Center for Drug Evaluation and Research
E11 Clinical Investigation of Medicinal Products in the Pediatric Population
Guidance DocumentDecember 15, 2000Center for Drug Evaluation and Research
Container Closure Systems for Packaging Human Drugs and Biologics: Guidance for Industry
Guidance DocumentJuly 7, 1999Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox